Pituitary disease mortality: is it fiction?

Research output: Contribution to journalArticlepeer-review


During the last 20 years a tremendous improvement in the care of patients with pituitary tumors and of hypopituitarism has been achieved. If we resolve most of the possible causes of the increased cardiovascular disease and stroke mortality a normal survival is expected in these patients. Recently, a large population based study showed a decline in the risk of non-fatal stroke and of non-fatal cardiac events in GH deficient patients. This improvement was achieved by complete hormone replacement, including long term GH replacement, together with prescription of cardio protective drugs. If we follow the latest achievements in pituitary imaging, surgery techniques, hormone substitutions, cardio protective medications, we would expect a normal longevity in these patients. This review will focus on; (1) pituitary insufficiencies and hormone substitutions, (2) modes of cranial radiotherapy, and (3) new techniques in the surgery of a pituitary adenoma.
Original languageEnglish
Pages (from-to)402-412
Issue number3
Publication statusPublished - 2013

Subject classification (UKÄ)

  • Endocrinology and Diabetes


Dive into the research topics of 'Pituitary disease mortality: is it fiction?'. Together they form a unique fingerprint.

Cite this